Document Detail


Improvement of myoclonic epilepsy in Down syndrome treated with levetiracetam.
MedLine Citation:
PMID:  20483713     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Late Onset Myoclonic Epilepsy in Down Syndrome (LOMEDS) is a recognized entity usually preceded by cognitive deterioration. We report two patients with LOMEDS and cognitive decline, aged 52 and 44 years. Continuous video-EEG recording showed generalised spike and slow wave complexes as an ictal correlate of the myoclonic jerks in both patients. Low dose levetiracetam resulted in rapid, sustained seizure freedom in both patients with no reported adverse events. As for other myoclonic epilepsies, levetiracetam appears to be effective for the treatment of LOMEDS, and may be considered as a first line agent for this disorder.
Authors:
Masoud Sangani; Asim Shahid; Shahram Amina; Mohamad Koubeissi
Related Documents :
11701263 - Early epileptic encephalopathies including west syndrome: a 3-year retrospective study ...
8072433 - Hoigné's syndrome: a procaine-induced limbic kindling.
3354003 - Teratogenic effects of benzo[a]pyrene in developing chick embryo.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2010-05-20
Journal Detail:
Title:  Epileptic disorders : international epilepsy journal with videotape     Volume:  12     ISSN:  1294-9361     ISO Abbreviation:  Epileptic Disord     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-21     Completed Date:  2010-09-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100891853     Medline TA:  Epileptic Disord     Country:  France    
Other Details:
Languages:  eng     Pagination:  151-4     Citation Subset:  IM    
Affiliation:
Department of Neurology, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Alzheimer Disease / diagnosis
Anticonvulsants / therapeutic use*
Disease Progression
Dose-Response Relationship, Drug
Down Syndrome / diagnosis,  drug therapy*
Drug Administration Schedule
Electroencephalography / drug effects
Epilepsies, Myoclonic / diagnosis,  drug therapy*
Humans
Middle Aged
Piracetam / analogs & derivatives*,  therapeutic use
Signal Processing, Computer-Assisted
Chemical
Reg. No./Substance:
0/Anticonvulsants; 33996-58-6/etiracetam; 7491-74-9/Piracetam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Superimposed linear lichen planopilaris: another polygenic disorder exemplifying a new genetic conce...
Next Document:  Absence seizures with myoclonic features in a juvenile Chihuahua dog.